Stimulant treatment of adult ADHD

ADHD in Adults: Characterization, Diagnosis, and Treatment

Volumn , Issue , 2011, Pages 191-197

  Spencer, Thomas ^a   Biederman, Joseph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927008793     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511780752.017     Document Type: Chapter

References (21)

1. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association
2. Biederman J, Faraone S, Mick E. (2000). Age dependent decline of ADHD symptoms revisited: Impact of remission definition and symptom subtype. Am J Psychiatry 157:816–17.
3. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, et al. (2006). A randomized, placebocontrolled trial of OROS-methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 59:829–35.
4. Biederman J, Wilens T, Mick E, Milberger S, Spencer T, Faraone S. (1995). Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder: effects of ADHD and psychiatric comorbidity. Am J Psychiatry 152:1652–8.
5. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. (1999). Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104:e20.
6. Brown RT, Wynne ME, Slimmer LW. (1984). Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning. J Clin Psychiatry 45:473–6.
7. Faraone S., Sergeant J, Gillberg C, Biederman J. (2003). The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104–13.
8. Gualtieri CT, Ondrusek MG, Finley C. (1985). Attention deficit disorders in adults. Clin Neuropharmacol 8:343–56.
9. Gutgesell H, Atkins D, Barst R, Buck M, Franklin W, Humes R, et al. (1999). Cardiovascular monitoring of children and adolescents receiving psychotropic drugs. Circulation 99:979–82.
10. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. (2006).The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716–23.
11. Kooij JJ, Burger H, Boonstra AM, Van Der Linden PD, Kalma LE, Buitelaar JK. (2004). Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebocontrolled double-blind cross-over trial. Psychol Med 34:973–82.
12. Mattes JA, Boswell L, Oliver H. (1984). Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 41:1059–63.
13. Reimherr FW, Williams ED, Strong RE, Mestas R, Soni P, Marchant BK. (2007). A double-blind, placebocontrolled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry 68: 93–101.
14. Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L. (2006). Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 61(12):1380–7.
15. Spencer T, Biederman J, Wilens T, Faraone S. (1994). Is attention deficit hyperactivity disorder in adults a valid disorder? Harv Rev Psychiatry 1:326–35.
16. Spencer T, Biederman J, Wilens T, Faraone S., Doyle RD, Surman C, et al. (2005). A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57:456–63.
17. Spencer T, Biederman J, Wilens T, Faraone S, Prince J, Gerard K, et al. (2001). Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 58:775–82.
18. Spencer T, Wilens T, Biederman J, Faraone S., Ablon JS, Lapey K. (1995). A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 52:434–43.
19. Weisler R, Biederman J, Spencer TJ, et al. (2004). Mixed amphetamine salts extended release (Adderall XRR) in the treatment of adult attention-deficit/hyperactivity disorder: a randomized, controlled trial. Paper presented at: Annual Meeting of the American Psychiatric Association; New York.
20. Wender PH, Reimherr FW, Wood DR, Ward M. (1985). A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 142:547–52.
21. Wood DR, Reimherr FW, Wender PH, Johnson GE. (1976). Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry 33:1453–60.